NTAGI mulls 'additional' Covid jab for immunocompromised

The issue of administering 'additional' dose of COVID-19 vaccine to immunocompromised individuals will be deliberated upon in the meeting of the National Technical Advisory Group on Immunisation......

Vaccine for children over 12 yrs likely by Aug: NTAGI chief

Zydus Cadila COVID-19 vaccine for children above 12 years is expected to be available by August as its trials are likely to be completed by July-end, said Dr N K Arora, Chairman, National Technical......

Delta plus has more affinity for lung tissues: NTAGI chief

The Delta plus variant of COVID-19 has greater affinity to lung tissues as compared to other strains but it does not mean that it will cause severe disease or is more transmissible, head of......

Covishield dose gap reduced to 8-16 weeks from 12-16

India's apex body on immunisation National Technical Advisory Group on Immunisation or NTAGI has recommended administering the second dose of COVID-19 vaccine Covishield between eight and 16 weeks......